MedPath
NMPA Approval

Mirtazapine Tablets

国药准字HJ20250044

April 15, 2025

Drug Information

米氮平片

片剂

30mg

化学药品

April 15, 2025

April 14, 2030

Company Information

Applicant Company

F-4 & F-12, MIDC, MALEGAON, TAL. SINNAR, NASHIK 422113 MAHARASHTRA STATE, INDIA

Manufacturing Company

F-4 & F-12, MIDC, MALEGAON, TAL. SINNAR, NASHIK 422113 MAHARASHTRA STATE, INDIA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

米氮平片 - NMPA 批准文号 | MedPath